CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-19 | DiPaolo Mark Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2025-05-19 | Schlesinger Sarah J. Director | Grant or award | +12,077 | 130,706 | ||
| 2025-05-19 | Schlesinger Sarah J. Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2025-05-19 | Haimovitz Jules Director | Grant or award | +12,077 | 142,906 | ||
| 2025-05-19 | Haimovitz Jules Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,000 | ||
| 2025-05-15 | Raifeld Pavel 10% owner | Grant or award | +1,860 | 51,840 | ||
| 2025-05-15 | Basso Stephen Chief Financial Officer | Grant or award | +1,353 | 23,755 | ||
| 2025-03-14 | Raifeld Pavel 10% owner | Grant or award | +37,377 | $17.39 | $650K | 49,980 |
| 2025-03-14 | Raifeld Pavel 10% owner | Grant or award · Non-statutory Stock Option | +243,750 | 1,068,750 | ||
| 2025-03-06 | DENNER ALEXANDER J 10% owner | Sale | −1,196,746 | $17.52 | $21.0M | 5,658,705 |
| 2025-03-05 | DENNER ALEXANDER J 10% owner | Sale | −270,374 | $17.63 | $4.8M | 6,855,451 |
| 2025-03-04 | DENNER ALEXANDER J 10% owner | Sale | −151,175 | $17.63 | $2.7M | 7,125,825 |
| 2025-02-24 | Zhen Marianne Chief Accounting Officer | Grant or award | +8,938 | $18.08 | $162K | 51,312 |
| 2025-02-24 | Zhen Marianne Chief Accounting Officer | Grant or award · Non-statutory Stock Option | +30,300 | 93,322 | ||
| 2025-02-24 | Basso Stephen Chief Financial Officer | Grant or award | +10,569 | $18.08 | $191K | 22,402 |
| 2025-02-24 | Basso Stephen Chief Financial Officer | Grant or award · Non-statutory Stock Option | +100,831 | 276,730 | ||
| 2025-02-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −2,565 | $18.07 | $46K | 42,374 |
| 2025-02-20 | Basso Stephen Chief Financial Officer | Shares withheld for taxes | −1,106 | $18.07 | $20K | 11,833 |
| 2024-11-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −976 | $19.15 | $19K | 44,939 |
| 2024-11-15 | Basso Stephen Chief Financial Officer | Grant or award | +843 | 12,939 |
Page 3 of 10 · 181 trades